Neurocrine Biosciences Launches Interactive Digital Tool for use by Healthcare Providers to Help Expand Education on Identifying and Diagnosing Tardive Dyskinesia
![img: Featured](/wp-content/themes/neurocrine/assets/img/feature-5.jpg)
SAN DIEGO , Nov. 8, 2023 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the availability of DISCOVER TD ™ , an interactive digital tool designed to help healthcare providers learn about and identify tardive dyskinesia. Built in collaboration with clinical experts